| Name | Title | Contact Details |
|---|
Founded in 2018 by professors of Yale University and Columbia University, CertiK is a pioneer in blockchain security, utilizing best-in-class AI technology to secure and monitor blockchain protocols and smart contracts. CertiK`s mission is to secure the cyber world. Starting with blockchain, CertiK applies cutting-edge innovations from academia into enterprise, enabling mission-critical applications to be built with security and correctness. CertiK is one of the fastest growing and most trusted companies in blockchain security and has become a true market leader. To date, we have collectively worked with over 2500 enterprise clients, helped secure over $310 billion worth of digital assets, and detected over 45,000 vulnerabilities in blockchain code. Our clients include leading projects such as Aave, Polygon, Binance Smart Chain, Terra, Yearn, and Chiliz. CertiK just raised over $140 million and backed by Coatue, Tiger Global, Sequoia, and Hillhouse Capital.
Automattic wants to make the web a better place. Our family includes Jetpack, WooCommerce, Longreads, WordPress.com, and more.
BlueVoyant`s approach to cybersecurity revolves around three key pillars — technology, telemetry, and talent — that deliver rock-solid cyber defense capabilities to more than 700 enterprise customers across the globe. In the public sector, BlueVoyant Terrain: Supply Chain Defense for Government™️ provides an end-to-end supply chain risk management solution for government organizations charged with defending the health and security of mission-critical programs and industrial bases. BlueVoyant`s machine learning-driven automation and human-led expertise allows government stakeholders to illuminate multiple tiers of complex supply chain ecosystems, persistently monitor for both business continuity and cybersecurity-related risks, and rapidly take action to protect against vulnerabilities and threats.
Valo Tx is developing PeptiCRAd Technology: A platform for targeted cancer immunotherapy that synergistically combines oncolytic viruses and peptide vaccines
Make More Doing What You Love!